ALT5 Sigma CFO reports 25K vested RSUs and 125K warrants (05/30/2025)

Rhea-AI Filing Summary

Virland A. Johnson, identified as the issuer's Chief Financial Officer, reported transactions dated 05/30/2025 under the issuer listed as ALT5 Sigma Corp (ALTS). On that date he received 25,000 common shares that vested as Restricted Stock Units under the company's 2024 Equity Incentive Plan at a reported per-share amount of $0.01, leaving him with 38,000 shares beneficially owned after the transaction. He also acquired 125,000 warrants with a conversion/exercise price of $9.31, exercisable on 05/30/2025 and expiring on 05/30/2030, representing the right to purchase 125,000 additional common shares. The Form 4 notes the RSUs vested on the transaction date and lists the holdings as direct beneficial ownership.

Positive

• CFO received 25,000 vested RSUs under the 2024 Equity Incentive Plan, increasing direct ownership to 38,000 shares.
• Acquisition of 125,000 warrants recorded with explicit terms: conversion price $9.31, exercisable 05/30/2025, expiring 05/30/2030, creating a clear, quantifiable upside if exercised.

Negative

• None.

Insights

Financial Analyst

TL;DR: CFO received vested RSUs and warrants; transaction shows insider equity compensation rather than open-market purchase.

The filing documents a compensation-driven acquisition: 25,000 RSU shares vested (reported at $0.01 per share) and 125,000 warrants were recorded with a $9.31 exercise price and a 05/30/2030 expiry. For investors, the RSU vesting increases the CFO's direct stake to 38,000 shares, while the warrants, if exercised, could convert to 125,000 additional shares. This is a routine insider compensation disclosure; the filing does not report open-market buying or selling activity.

Corporate Governance Expert

TL;DR: Routine equity-based compensation event disclosed; aligns executive incentives with shareholders but increases potential share count.

The Form 4 indicates the company used its 2024 Equity Incentive Plan to grant RSUs that vested and to record outstanding warrants tied to the CFO. Such grants are standard for retention and alignment purposes. The filing directly states vesting and the warrants' terms ($9.31 strike; exercisable 05/30/2025; expire 05/30/2030), allowing assessment of potential future dilution. There is no indication in the filing of departures, sales, or unusual trading arrangements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Virland A

(Last) (First) (Middle)

325 E. WARM SPRINGS RD.

(Street)

LAS VEGAS NV 89119

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALT5 Sigma Corp [ ALTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
05/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/30/2025		A		25,000	A	$0.01(1)	38,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (Right to Buy)	$9.31	05/30/2025		A		125,000		05/30/2025	05/30/2030	Common Stock	125,000	$0	125,000	D

Explanation of Responses:

1. Restricted Stock Units were granted to the Reporting Person pursuant to the Issuer's 2024 Equity Incentive Plan, each of which vested on the Transaction Date.

Remarks:

	/s/ Virland A. Johnson	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 and what is their role at ALT5 Sigma?

The Form 4 was filed by Virland A. Johnson, who is listed as the company's CFO.

What securities did the insider acquire on 05/30/2025?

The insider received 25,000 common shares from vested RSUs and acquired 125,000 warrants on 05/30/2025.

What were the terms of the warrants reported on the Form 4?

The warrants have a conversion/exercise price of $9.31, are exercisable on 05/30/2025, and expire on 05/30/2030, covering 125,000 common shares.

At what price were the RSU shares recorded?

The RSU shares were reported at a per-share amount of $0.01 in the Form 4.

How many common shares does the reporting person beneficially own after the transaction?

Following the reported transaction, the Form 4 lists the reporting person as beneficially owning 38,000 common shares.